Human Diagnostics Announces the Acquisition of LABiTec

Human Diagnostics (HUMAN Gesellschaft für Biochemica and Diagnostica GmbH; Wiesbaden, Germany), a global provider of diagnostic products, clinical analyzers, reagents, and medical laboratory supplies, has acquired all shares of LABiTec (LAbor BioMedical Technologies GmbH; Ahrensburg, Germany), a global supplier of systems for blood coagulation and aggregation diagnostics. The purchase price was not disclosed

LABiTec specializes in the development, manufacture, and marketing of analyzers for coagulation diagnostics and platelet function testing (aggregation), with over 10,000 systems installed among 56 countries. LABiTec becoming part of the HUMAN group strengthens HUMAN’s technological expertise for the in-house development and the production of laboratory diagnostic analysis systems in the area of coagulation. The step also enhances its product range in the near-term with an automatic coagulation analyzer. LABiTec will continue its presence as an independent company in world market.

HUMAN's Managing Director, Ralph Neuberger, said, "We are very pleased to welcome LABiTec to our group. The excellent reputation of the brand LABiTec, technologically superior products, and the outstanding development competence are important pillars upon which, together, we can further expand our international market position." Hartmut Kehrbach, former owner of LABiTec who will stay on as a consultant, added, "For me, HUMAN, with its impressive global presence, is the ideal partner for LABiTec. I am convinced that LABiTec can make a significant contribution to the continued growth of the HUMAN group."

HUMAN was advised in this transaction by the consultancy CFP BioConnect AG, which specializes in the life sciences sector and is part of the Corporate Finance Partners Group in Frankfurt. Legal consulting was provided by the law firm Taylor Wessing, Hamburg.

Related Links:
HUMAN
LABiTec